Vycor Medical, Inc.
VYCO
$0.0679
-$0.0001-0.15%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 92.80% | -15.22% | -114.62% | -543.48% | 20.09% |
| Total Depreciation and Amortization | 11.92% | 3.29% | 3.97% | 1.30% | -1.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 736.36% | 67.86% | -100.00% | 160.71% | 4.76% |
| Change in Net Operating Assets | -182.27% | 162.63% | 210.76% | 2,475.00% | 23.40% |
| Cash from Operations | -796.36% | 170.47% | 505.63% | -92.28% | 116.47% |
| Capital Expenditure | 103.39% | -25.71% | -- | -- | -2,066.67% |
| Sale of Property, Plant, and Equipment | -- | -40.00% | -100.00% | 133.33% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 103.39% | -25.00% | -100.00% | 133.33% | -2,066.67% |
| Total Debt Issued | 100.00% | -3.33% | -- | -- | -101.69% |
| Total Debt Repaid | -43.30% | 1.75% | -0.95% | -13.48% | 84.58% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -21.93% | -4.64% | -20.45% | -13.48% | -130.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -340.68% | 143.95% | 1,246.43% | -224.07% | -362.22% |